| Rory J Makielski, MD | |
|
5 Deer Hollow Ct, Madison, WI 53717-2703 | |
| (608) 770-7679 | |
| Not Available |
| Full Name | Rory J Makielski |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Hematology & Oncology |
| Location | 5 Deer Hollow Ct, Madison, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750600557 | NPI | - | NPPES |
| 1750600557 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 60874-20 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Rory J Makielski, MD 5 Deer Hollow Ct, Madison, WI 53717-2703 Ph: () - | Rory J Makielski, MD 5 Deer Hollow Ct, Madison, WI 53717-2703 Ph: (608) 770-7679 |
News Archive
UT Southwestern Medical Center investigators have uncovered new insights on adolescent fighting: what triggers it, and how to stem it. Varied real-life factors pile on daily to put teens on edge: destructive behaviors like drug abuse, drinking or high-risk sexual encounters; poverty; academic troubles; and even depression. Data analyzed by researchers at UT Southwestern suggests that when teens perceive support from their families and/or schools, it can help mitigate violence.
The Population Council published new research in the November issue of the journal Contraception demonstrating that an investigational one-year contraceptive vaginal ring containing Nestorone and ethinyl estradiol was found to be highly acceptable among women enrolled in a Phase 3 clinical trial.
A new gene therapy technique that has shown promise in skin disease and hemophilia might one day be useful for treating muscular dystrophy, according to a new study by researchers at Stanford University School of Medicine.
A biologist at The University of Texas at Arlington is using a new grant to look for ways to finish off a disease that has stubbornly resisted all attempts to eradicate it.
Octapharma AG today announced the start of the first of a series of Phase III studies for its new 10% high purity intravenous immunoglobulin (IVIG). The study will investigate the efficacy and safety of this novel immunoglobulin in the treatment of primary immune deficiency and, together with results from additional upcoming studies, will support its regulatory filing in Europe and the US.
› Verified 2 days ago
Prof. Marvin Lyle Birnbaum, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 3330 University Ave, Suite 300, Madison, WI 53705 Phone: 608-263-9641 Fax: 608-265-4429 | |
Yingyu Gao, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 600 Highland Ave, Madison, WI 53792 Phone: 608-263-6400 | |
Dr. Sam Joseph Lubner, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 600 Highland Ave, Madison, WI 53792 Phone: 608-265-1700 | |
Randy S Heidel, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 20 S Park St, Madison, WI 53715 Phone: 608-287-2250 Fax: 608-287-2438 | |
Benjamin Kleiber, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 700 S Park St, Dean & St. Mary's Outpatient Center, Madison, WI 53715 Phone: 608-260-2900 Fax: 608-260-2956 | |
N Thomas Casper, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3102 Meriter Way, Madison, WI 53719 Phone: 608-417-8800 | |
Philip Tepper Cohen, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 5154 Juneau Rd, Madison, WI 53705 Phone: 608-441-2512 Fax: 608-441-2512 |